2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$5.81$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $219.2MMarket Cap
- 405.22%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$5.81$0.00 (0.00%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.81 | ||
Change | +$0.02 (+0.35%) | ||
Open | $5.84 | ||
High | $5.89 | ||
Low | $5.50 | ||
Previous Close | $5.79 | ||
Volume | 225,449 | ||
30-Day Average Volume | 205,725 | ||
1-Week Change | -3.01% | ||
1-Month Change | 16.20% | ||
1-Year Change | 405.22% | ||
3-Year Change | -57.75% | ||
5-Year Change | -89.78% | ||
Fundamentals | |||
Shares Outstanding | 37.7M | ||
Total Assets | $81.7M | ||
Market Cap | $219.2M | ||
Enterprise Value | $174.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.2M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$8.2M | ||
EBITDA | -$8.2M | ||
Net Working Capital | $74.4M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -32 | ||
PEG | -1 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue